12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

1 de July de 2026

INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents

1 de July de 2026

Joint FOJURJ Ordinance No. 4/2026 was recently published, creating the Permanent Industrial Property Committee within the Judiciary Forum of the State of … Joint Judiciary Ordinance Creates Permanent Industrial Property Committee and Strengthens Cooperation Between State and Federal Courts

30 de June de 2026

By means of Ordinance 05/2026, published on June 30, 2026, the BPTO has announced that a new cycle for fast-track examination routes, … New Cycle for Fast-track Examination Requests, Including PPH, Opens in Brazil for Telecommunication Cases